IGF1R and lung adenocarcinoma: In lung adenocarcinoma cells, fibulin-3 demonstrates inhibitory effects on EMT and self-renewal capacity by suppressing β-catenin through insulin-like growth factor-1 receptor (IGF1R)/phosphatidylinositide 3-kinase (PI3K)/AKT signaling pathways [82].